Nationwide surveillance of the antimicrobial susceptibility of Neisseria gonorrhoeae from male urethritis in Japan

Journal of Infection and Chemotherapy

Volumn 19, Issue 4, 2013, Pages 571-578

  Hamasuna, Ryoichi ^a,c   Yasuda, Mitsuru ^a,d   Ishikawa, Kiyohito ^a,e   Uehara, Shinya ^a,f   Takahashi, Satoshi ^a,g   Hayami, Hiroshi ^a,h   Yamamoto, Shingo ^a,i   Matsumoto, Tetsuro ^a,c   Minamitani, Shinichi ^a   Watanabe, Akira ^ap   Iwamoto, Aikichi ^ap   Totsuka, Kyoichi ^ap   Kadota, Junichi ^ap   Sunakawa, Keisuke ^ap   Sato, Junko ^ap   Hanaki, Hideaki ^b   Tsukamoto, Taiji ^g   Kiyota, Hiroshi ^j   Egawa, Shin ^j   Tanaka, Kazushi ^k   Arakawa, Soichi ^k   Fujisawa, Masato ^k   Kumon, Hiromi ^f   Kobayashi, Kanao ^l   Matsubara, Akio ^l   Naito, Seiji ^m   Tatsugami, Katsunori ^m   Ito, Shin ⁿ   Narita, Harunori ^o   Kanokogi, Mototsugu ^p   Sumii, Toru ^q   Ito, Kenji ^r   Hosobe, Takahide ^s   Kawai, Shuichi ^t   Kawano, Hiromi ^u   Takayama, Kazuo ^v   Yamaguchi, Takamasa ^w   Endo, Katsuhisa ^x   Yamauchi, Takamine ^y   Maeda, Shinichi ^z   Yoh, Mutsumasa ^aa   Horie, Masanobu ^ab   Ito, Masayasu ^ac   Chokyu, Hirofumi ^ad   Ihara, Hideari ^ae   Akiyama, Kikuo ^af   Uno, Satoshi ^ag   Monden, Koichi ^ah   Kaji, Shinichi ^ai   Nishimura, Hirofumi ^aj   Kawahara, Motoshi ^ak   Sato, Takashi ^al   Konishi, Takatoshi ^am   Nishi, Shohei ^u   Ishihara, Satoshi ^an   Yoshioka, Masaru ^ao   more..

^a Japanese Association for Infectious Diseases (JAID)   (Japan)

^b KITASATO INSTITUTE   (Japan)

^c UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

^d GIFU UNIVERSITY   (Japan)

^e FUJITA HEALTH UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^f OKAYAMA UNIVERSITY   (Japan)

^g SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^h KAGOSHIMA UNIVERSITY HOSPITAL   (Japan)

ⁱ HYOGO COLLEGE OF MEDICINE   (Japan)

^j JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^k KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^l HIROSHIMA UNIVERSITY   (Japan)

^m KYUSHU UNIVERSITY   (Japan)

ⁿ IClinic   (Japan)

^o Narita Clinic   (Japan)

^p Kanokogi Urological Clinic   (Japan)

^q Sumii Clinic   (Japan)

^r Ito Urology Clinic   (Japan)

^s Hosobe Clinic   (Japan)

^t Kawai Urology Clinic   (Japan)

^u Kawano Urol and Dermatologic Clinic   (Japan)

^v Takayama Hospital   (Japan)

^w Yamaguchi Dermatology and Urology Clinic   (Japan)

^x JR Tokyo General Hospital   (Japan)

^y Yamauchi Urological Clinic   (Japan)

^z TOYOTA MEMORIAL HOSPITAL   (Japan)

^aa Yoh Urology and Dermatology Clinic   (Japan)

^ab Daiyukai Daiichi Hospital   (Japan)

^ac Gifu Urology Clinic   (Japan)

^ad Chokyu Tenma Clinic   (Japan)

^ae Ihara Clinic   (Japan)

^af Akiyama Urological Clinic   (Japan)

^ag Hirajima Clinic   (Japan)

^ah Araki Urological Clinic   (Japan)

^ai Kaji Clinic   (Japan)

^aj Nishimura Urology Clinic   (Japan)

^ak Kawahara Urology Clinic   (Japan)

^al Nissin Urological Clinic   (Japan)

^am National Hospital Organization   (Japan)

^an Kizawa Memorial Hospital   (Japan)

^ao Yoshioka Urological Clinic   (Japan)

^ap JAID and JSCM   (Japan)

more..

Author keywords

Antimicrobial susceptibilities; Japan; Nationwide surveillance; Neisseria gonorrhoeae

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; AZITHROMYCIN; AZTREONAM; BETA LACTAMASE; CEFDINIR; CEFDITOREN; CEFIXIME; CEFODIZIME; CEFPODOXIME; CEFTRIAXONE; CIPROFLOXACIN; FLOMOXEF; LEVOFLOXACIN; MACROLIDE; MINOCYCLINE; PENICILLIN G; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SITAFLOXACIN; SPECTINOMYCIN; TOSUFLOXACIN;

ADOLESCENT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; GONOCOCCAL URETHRITIS; HUMAN; JAPAN; MALE; MINIMUM INHIBITORY CONCENTRATION; NEISSERIA GONORRHOEAE; NONHUMAN;

ADOLESCENT; ADULT; AGED; ANTI-BACTERIAL AGENTS; DRUG RESISTANCE, BACTERIAL; HUMANS; JAPAN; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; NEISSERIA GONORRHOEAE; PREVALENCE; PUBLIC HEALTH SURVEILLANCE; URETHRITIS;

EID: 84882236589     PISSN: 1341321X     EISSN: 14377780     Source Type: Journal    
DOI: 10.1007/s10156-013-0637-2     Document Type: Article

References (26)

1. Surveillance of antibiotic resistance in Neisseria gonorrhoeae in the WHO Western Pacific Region, 2006. Commun Dis Intell 2008;32(1):48-51.
2. Surveillance of antibiotic resistance in Neisseria gonorrhoeae in the WHO Western Pacific and South East Asian Regions, 2009. Commun Dis Intell 2011;35(1):2-7.
3. Yoshida S, Urabe S, Mizuguchi Y. Antibiotic sensitivity patterns of penicillinase-positive and penicillinase-negative strains of Neisseria gonorrhoeae isolated in Fukuoka, Japan. Br J Vener Dis. 1982;58(5):305-7.
4. Akasaka S, Muratani T, Yamada Y, Inatomi H, Takahashi K, Matsumoto T. Emergence of cephem- and aztreonam-high-resistant Neisseria gonorrhoeae that does not produce beta-lactamase. J Infect Chemother. 2001;7(1):49-50.
5. Workowski KA, Berman S. Sexually transmitted diseases treatment guidelines, 2010. MMWR Recomm Rep. 2010;59(RR-12):1-110.
6. Deguchi T, Yasuda M, Yokoi S, Ishida K, Ito M, Ishihara S, et al. Treatment of uncomplicated gonococcal urethritis by double-dosing of 200 mg cefixime at a 6-h interval. J Infect Chemother. 2003;9(1):35-9.
7. Ito M, Deguchi T, Mizutani KS, Yasuda M, Yokoi S, Ito S, et al. Emergence and spread of Neisseria gonorrhoeae clinical isolates harboring mosaic-like structure of penicillin-binding protein 2 in Central Japan. Antimicrob Agents Chemother. 2005;49(1):137-43.
8. Ohnishi M, Saika T, Hoshina S, Iwasaku K, Nakayama S, Watanabe H, et al. Ceftriaxone-resistant Neisseria gonorrhoeae, Japan. Emerg Infect Dis. 2011;17(1):148-9.
9. Shigemura K, Okada H, Shirakawa T, Tanaka K, Arakawa S, Kinoshita S, et al. Susceptibilities of Neisseria gonorrhoeae to fluoroquinolones and other antimicrobial agents in Hyogo and Osaka, Japan. Sex Transm Infect. 2004;80(2):105-7.
10. Tanaka M, Nakayama H, Notomi T, Irie S, Tsunoda Y, Okadome A, et al. Antimicrobial resistance of Neisseria gonorrhoeae in Japan, 1993-2002: continuous increasing of ciprofloxacin-resistant isolates. Int J Antimicrob Agents. 2004;24(suppl 1):S15-22.
11. Palmer HM, Young H, Winter A, Dave J. Emergence and spread of azithromycin-resistant Neisseria gonorrhoeae in Scotland. J Antimicrob Chemother. 2008;62(3):490-4.
12. Tanaka M, Koga Y, Nakayama H, Kanayama A, Kobayashi I, Saika T, et al. Antibiotic-resistant phenotypes and genotypes of Neisseria gonorrhoeae isolates in Japan: identification of strain clusters with multidrug-resistant phenotypes. Sex Transm Dis. 2011;38(9):871-5.
13. Osaka K, Takakura T, Narukawa K, Takahata M, Endo K, Kiyota H, et al. Analysis of amino acid sequences of penicillin-binding protein 2 in clinical isolates of Neisseria gonorrhoeae with reduced susceptibility to cefixime and ceftriaxone. J Infect Chemother. 2008;14(3):195-203.
14. Takahashi S, Kurimura Y, Hashimoto J, Uehara T, Hiyama Y, Iwasawa A, et al. Antimicrobial susceptibility and penicillin-binding protein 1 and 2 mutations in Neisseria gonorrhoeae isolated from male urethritis in Sapporo, Japan. J Infect Chemother. 2013;19:50-6.
15. Watanabe A, Yanagihara K, Matsumoto T, Kohno S, Aoki N, Oguri T, et al. Nationwide surveillance of bacterial respiratory pathogens conducted by the Surveillance Committee of Japanese Society of Chemotherapy, Japanese Association for Infectious Diseases, and Japanese Society for Clinical Microbiology in 2009: general view of the pathogens' antibacterial susceptibility. J Infect Chemother. 2012;18:609-20.
16. Ishikawa K, Matsumoto T, Yasuda M, Uehara S, Muratani T, Yagisawa M, et al. The nationwide study of bacterial pathogens associated with urinary tract infections conducted by the Japanese Society of Chemotherapy. J Infect Chemother. 2011;17(1):126-38.
17. Clinical and Laboratory Standards Institutes. Performance standards for antimicrobial susceptibility testing: eighteenth informational supplement M100-S182008. Wayne, PA: CLSI; 2008.
18. Kamidono S, Onodera S, Kishimoto S. Guideline for diagnosis and treatment for sexually transmitted infections, 2011 (in Japanese). Jpn J Sex Transm Infect. 2011;22(1 suppl):1-163.
19. Deguchi T, Yasuda M, Maeda S. Lack of nationwide surveillance of antimicrobial resistance of Neisseria gonorrhoeae in Japan. Ann Intern Med. 2008;149(5):363-4.
20. Nakayama S, Tribuddharat C, Prombhul S, Shimuta K, Srifuengfung S, Unemo M, et al. Molecular analyses of TEM genes and their corresponding penicillinase-producing Neisseria gonorrhoeae isolates in Bangkok, Thailand. Antimicrob Agents Chemother. 2012;56(2):916-20.
21. Ohnishi M, Golparian D, Shimuta K, Saika T, Hoshina S, Iwasaku K, et al. Is Neisseria gonorrhoeae initiating a future era of untreatable gonorrhea? Detailed characterization of the first strain with high-level resistance to ceftriaxone. Antimicrob Agents Chemother. 2011;55(7):3538-45.
22. Unemo M, Golparian D, Nicholas R, Ohnishi M, Gallay A, Sednaoui P. High-level cefixime- and ceftriaxone-resistant Neisseria gonorrhoeae in France: novel penA mosaic allele in a successful international clone causes treatment failure. Antimicrob Agents Chemother. 2012;56(3):1273-80.
23. Yokoi S, Deguchi T, Ozawa T, Yasuda M, Ito S, Kubota Y, et al. Threat to cefixime treatment for gonorrhea. Emerg Infect Dis. 2007;13(8):1275-7.
24. Hamasuna R, Takahashi S, Uehara S, Matsumoto T. Should urologists care for the pharyngeal infection of Neisseria gonorrhoeae or Chlamydia trachomatis when we treat male urethritis? J Infect Chemother. 2012;18(3):410-3.
25. Muratani T, Inatomi H, Ando Y, Kawai S, Akasaka S, Matsumoto T. Single dose 1 g ceftriaxone for urogenital and pharyngeal infection caused by Neisseria gonorrhoeae. Int J Urol. 2008;15(9):837-42.
26. Matsumoto T, Hamasuna R, Ishikawa K, Takahashi S, Yasuda M, Hayami H, et al. Sensitivities of major causative organisms isolated from patients with acute uncomplicated cystitis against various antibacterial agents: results of subanalysis based on the presence of menopause. J Infect Chemother. 2012;18(4):597-607.